These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35280651)

  • 21. Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.
    Reustle A; Di Marco M; Meyerhoff C; Nelde A; Walz JS; Winter S; Kandabarau S; Büttner F; Haag M; Backert L; Kowalewski DJ; Rausch S; Hennenlotter J; Stühler V; Scharpf M; Fend F; Stenzl A; Rammensee HG; Bedke J; Stevanović S; Schwab M; Schaeffeler E
    Genome Med; 2020 Mar; 12(1):32. PubMed ID: 32228647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overall Survival Prediction in Renal Cell Carcinoma Patients Using Computed Tomography Radiomic and Clinical Information.
    Khodabakhshi Z; Amini M; Mostafaei S; Haddadi Avval A; Nazari M; Oveisi M; Shiri I; Zaidi H
    J Digit Imaging; 2021 Oct; 34(5):1086-1098. PubMed ID: 34382117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can whole-tumor radiomics-based CT analysis better differentiate fat-poor angiomyolipoma from clear cell renal cell caricinoma: compared with conventional CT analysis?
    Ma Y; Cao F; Xu X; Ma W
    Abdom Radiol (NY); 2020 Aug; 45(8):2500-2507. PubMed ID: 31980867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.
    Coy H; Hsieh K; Wu W; Nagarajan MB; Young JR; Douek ML; Brown MS; Scalzo F; Raman SS
    Abdom Radiol (NY); 2019 Jun; 44(6):2009-2020. PubMed ID: 30778739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT-based multi-phase Radiomic models for differentiating clear cell renal cell carcinoma.
    Chen M; Yin F; Yu Y; Zhang H; Wen G
    Cancer Imaging; 2021 Jun; 21(1):42. PubMed ID: 34162442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
    Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
    Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2D.
    Zwirner K; Hilke FJ; Demidov G; Socarras Fernandez J; Ossowski S; Gani C; Thorwarth D; Riess O; Zips D; Schroeder C; Welz S
    Strahlenther Onkol; 2019 Sep; 195(9):771-779. PubMed ID: 31123786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
    Katsoulakis E; Yu Y; Apte AP; Leeman JE; Katabi N; Morris L; Deasy JO; Chan TA; Lee NY; Riaz N; Hatzoglou V; Oh JH
    Oral Oncol; 2020 Nov; 110():104877. PubMed ID: 32619927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiomics models based on enhanced computed tomography to distinguish clear cell from non-clear cell renal cell carcinomas.
    Wang P; Pei X; Yin XP; Ren JL; Wang Y; Ma LY; Du XG; Gao BL
    Sci Rep; 2021 Jul; 11(1):13729. PubMed ID: 34215760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiogenomics Reveals Correlation between Quantitative Texture Radiomic Features of Biparametric MRI and Hypoxia-Related Gene Expression in Men with Localised Prostate Cancer.
    Ogbonnaya CN; Alsaedi BSO; Alhussaini AJ; Hislop R; Pratt N; Nabi G
    J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.
    Zheng Z; Chen Z; Xie Y; Zhong Q; Xie W
    Eur Radiol; 2021 Aug; 31(8):6078-6086. PubMed ID: 33515086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of clear cell and non-clear cell renal cell carcinomas by all-relevant radiomics features from multiphase CT: a VHL mutation perspective.
    Li ZC; Zhai G; Zhang J; Wang Z; Liu G; Wu GY; Liang D; Zheng H
    Eur Radiol; 2019 Aug; 29(8):3996-4007. PubMed ID: 30523454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
    Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive models composed by radiomic features extracted from multi-detector computed tomography images for predicting low- and high- grade clear cell renal cell carcinoma: A STARD-compliant article.
    He X; Zhang H; Zhang T; Han F; Song B
    Medicine (Baltimore); 2019 Jan; 98(2):e13957. PubMed ID: 30633175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept Study.
    Yin Q; Hung SC; Wang L; Lin W; Fielding JR; Rathmell WK; Khandani AH; Woods ME; Milowsky MI; Brooks SA; Wallen EM; Shen D
    Sci Rep; 2017 Mar; 7():43356. PubMed ID: 28256615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-transcriptome sequencing identified gene expression signatures associated with aggressive clear cell renal cell carcinoma.
    Batai K; Imler E; Pangilinan J; Bell R; Lwin A; Price E; Milinic T; Arora A; Ellis NA; Bracamonte E; Seligmann B; Lee BR
    Genes Cancer; 2018 May; 9(5-6):247-256. PubMed ID: 30603059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study.
    Ou J; Li R; Zeng R; Wu CQ; Chen Y; Chen TW; Zhang XM; Wu L; Jiang Y; Yang JQ; Cao JM; Tang S; Tang MJ; Hu J
    Cancer Imaging; 2019 Oct; 19(1):66. PubMed ID: 31619297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiogenomics in Clear Cell Renal Cell Carcinoma: A Review of the Current Status and Future Directions.
    Khaleel S; Katims A; Cumarasamy S; Rosenzweig S; Attalla K; Hakimi AA; Mehrazin R
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.